Feizhao Jiang
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Berberine and alkaloids research
Papers in
-
- Gut microbiota and health 2
- Ubiquitin and proteasome pathways 1
- Surgery 4
- Bariatric Surgery and Outcomes 2
- Co-authors
- Xuemeng Xie (3 shared papers)Ling Ji (3 shared papers)Zhihai Zheng (2 shared papers)Weijian Zhang (1 shared paper)Yongliang Lou (3 shared papers)Xiang Li (2 shared papers)Tingting Yu (2 shared papers)Zhenhua Zhou (1 shared paper)
- Journals
- Frontiers in Microbiology (2 papers)Surgery for Obesity and Related Diseases (2 papers)Journal of Macromolecular Science Part A (1 paper)Molecular Therapy — Nucleic Acids (1 paper)PLoS ONE (1 paper)
- Partner nations
- China
In The Last Decade
Feizhao Jiang
16 papers receiving 244 citations
Peers
Comparison fields: 5 of 49
- Cancer Research 92
- Pharmacology 31
- Pharmacology 16
- Molecular Biology 114
- Oncology 40
Countries citing papers authored by Feizhao Jiang
This map shows the geographic impact of Feizhao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feizhao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feizhao Jiang more than expected).
Fields of papers citing papers by Feizhao Jiang
This network shows the impact of papers produced by Feizhao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feizhao Jiang. The network helps show where Feizhao Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feizhao Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 55 | |
| 2 | 2021 | 46 | |
| 3 | 2019 | 34 | |
| 4 | 2016 | 31 | |
| 5 | 2022 | 13 | |
| 6 | [Comprehensive analysis of 203 cases with abdominal cocoon]. | 2006 | 13 |
| 7 | 2019 | 12 | |
| 8 | 2013 | 11 | |
| 9 | 2017 | 9 | |
| 10 | 2015 | 8 | |
| 11 | 2014 | 6 | |
| 12 | Diagnosis and treatment of mucobilia: report of 8 cases. | 2003 | 2 |
| 13 | [Duodenojejunal bypass in treatment for 7 cases with non-severe obese type 2 diabetes mellitus]. | 2012 | 2 |
| 14 | [Laparoscopic total mesorectal excision combined with intersphincteric resection for ultra-low rectal cancer]. | 2011 | 1 |
| 15 | [Factors influencing the long-term survival in pancreatic carcinoma patients after radical resection]. | 2008 | 1 |
| 16 | 2019 | 1 | |
| 17 | 2023 | 0 |
About Feizhao Jiang
Feizhao Jiang is a scholar working on Molecular Biology, Surgery, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 245 indexed citations. Recurring topics across this work include Gut microbiota and health (2 papers), Bariatric Surgery and Outcomes (2 papers), Cancer Mechanisms and Therapy (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Plant and Fungal Interactions Research (1 paper), Ubiquitin and proteasome pathways (1 paper), Ferroptosis and cancer prognosis (1 paper) and Berberine and alkaloids research (1 paper). The work is most often cited by research in Cancer Research (92 citations), Pharmacology (31 citations), Pharmacology (16 citations), Molecular Biology (114 citations) and Oncology (40 citations). Feizhao Jiang has collaborated with scholars based in China. Frequent co-authors include Xuemeng Xie, Ling Ji, Zhihai Zheng, Weijian Zhang, Yongliang Lou, Xiang Li, Tingting Yu, Zhenhua Zhou, Xiang Li and Xiaofeng Zheng. Their work appears in journals such as Frontiers in Microbiology, Surgery for Obesity and Related Diseases, Journal of Macromolecular Science Part A, Molecular Therapy — Nucleic Acids and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.